Novel Frontiers in the Production of Compounds for Biomedical Use Volume 1

Afbeeldingen

Artikel vergelijken

  • Engels
  • Hardcover
  • 9780792367475
  • 28 februari 2001
  • 454 pagina's
Alle productspecificaties

Samenvatting

Presents a selection of different approaches for the production of novel biotechnological compounds for biomedical applications. This book includes contributions linking genomics with bacterial resistance, antibiotics with improved production strategies, and optimised production approaches with chemical development programs.



The present book entitled “Novel Frontiers in the Production of Compounds for Biomedical Uses” can perhaps be placed in its best perspective by the Shakespearean character in The Tempest who exclaimed" What’s past is prologue”. Indeed, this compilation of some of the outstanding presentations in the field of biomedicine made at th the 9 European Congress on Biotechnology (Brussels, Belgium, July 11-15, 1999) not only reflects the achievements of the recent past, but provides a privileged glimpse of the biotechnology that is emerging in the first decade of the new Millennium. It is becoming increasingly apparent that biotechnology is offering biomedicine novel approaches and solutions to develop a sorely needed new generation of biopharmaceuticals. This is all the more necessary because in recent years, new diseases have emerged with extraordinary lethality in all corners of the globe, while age-related chronic illnesses have filled the gap wherever biomedicine has made successful inroads. The rise of antibiotic resistance also poses major threats to public health. Thus, as disease patterns evolve, the rational development of new drugs is becoming urgent, not only for the clinical outcome of patients, but also in optimising the allocation of scarce health care resources through the use of cost-effective productions methods. It is in response to all these challenges that biotechnology offers new strategies that go beyond the more traditional approaches. By the mid-1990’s, the number of recombinant products approved annually for therapeutic use reached double digits. With the advent of the genomics revolution.

Productspecificaties

Inhoud

Taal
en
Bindwijze
Hardcover
Oorspronkelijke releasedatum
28 februari 2001
Aantal pagina's
454
Illustraties
Nee

Betrokkenen

Hoofdauteur
Annie van Broekhoven
Tweede Auteur
Fred Shapiro
Co Auteur
Jozef Anne
Hoofdredacteur
A. van Broekhoven
Tweede Redacteur
Fred Shapiro
Co Redacteur
Jozef Anné
Hoofduitgeverij
Springer

Overige kenmerken

Editie
2001
Extra groot lettertype
Nee
Product breedte
155 mm
Product lengte
235 mm
Studieboek
Ja
Verpakking breedte
155 mm
Verpakking hoogte
29 mm
Verpakking lengte
235 mm
Verpakkingsgewicht
1820 g

EAN

EAN
9780792367475
Nog geen reviews

Kies gewenste uitvoering

Bindwijze : Hardcover

Prijsinformatie en bestellen

De prijs van dit product is 29 euro en 95 cent. Dit is een tweedehands product.
Alleen tweedehands
Goed
Keurige hardcover, stempeltje, nummer en stickertje voorin
Op voorraad
Voor 23:59 uur besteld, vrijdag in huis
  • Bestellen en betalen via bol
  • Prijs inclusief verzendkosten, verstuurd door J.M. van der Meer
  • 30 dagen bedenktijd en gratis retourneren
  • Doordeweeks ook ’s avonds in huis